The search for susceptibility genes

Placental Bed Disorders: Basic Science and its Translation to Obstetrics

Volumn , Issue , 2010, Pages 174-182

  Morgan, Linda ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927044187     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511750847.018     Document Type: Chapter

References (43)

1. Ward K, Argyle V, Meade M, Nelson L. The heritability of preterm delivery. Obstet Gynecol 2005; 106: 1235-9.
2. Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci 2006; 110: 443-58.
3. Clausson B, Lichtenstein P, Cnattingius S. Genetic influence on birthweight and gestational length determined by studies in offspring of twins. Br J Obstet Gynaecol 2000; 107: 375-81.
4. Lie RT, Rasmussen S, Brunborg H et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. Brit Med J 1998; 316: 1343-7.
5. Chesley L C, Annitto J E, Cosgrove R A. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968; 32: 303-11.
6. Cincotta RB, Brennecke S P. Family history of preeclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998; 60: 23-7.
7. Thornton J G, Macdonald A M. Twin mothers, pregnancy hypertension and pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 570-5.
8. Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing preeclampsia and gestational hypertension. AmJMed Genet 2000; 91: 256-60.
9. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population- based Swedish cohort study. Am J Med Genet 2004; A130: 365-71.
10. Lachmeijer A M A, Dekker G A, Pals G et al. Searching for preeclampsia genes: the current position. Eur J Obstet GynRB 2002; 105: 94-113.
11. Wilson M L, Goodwin T M, Pan V L, Ingles S A. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv 2003; 58: 39-66.
12. Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105: 182-92.
13. Dudding T E, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 2004; 91: 700-11.
14. Kosmas I P, Tatsioni A, Ioannidis J P A. Association of Leiden mutation in Factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003; 21: 1221-8.
15. Dudding T, Heron J, Thakkinstian A et al. Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis. J Thromb Haemost 2008; 6: 1868-75.
16. Cudworth A G, Woodrow J C. Evidence for HL-A- linked genes in “juvenile” diabetes mellitus. Br Med J 1975; 3(5976): 133-5.
17. Yu C-E, Payami H, Olson JM et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994; 54: 631-42.
18. Arngrimsson R, Sigurardottir S, Frigge ML et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999; 8: 1799-805.
19. Moses E K, Lade J A, Guo G et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am JHum Genet 2000; 67:1581-5.
20. Lachmeijer A M A, Arngrimsson R, Bastiaans E J et al. A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet 2001; 9: 758-64.
21. Laivuori H, Lahermo P, Ollikainen V et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Gene 2003; 72: 168-77.
22. Malecki M T. Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 68 (Suppl 1): S10-21.
23. Bird T D. Genetic aspects of Alzheimer disease. Genet Med 2008; 10: 231-9.
24. Moses EK, Fitzpatrick E, Freed K A et al. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod 2006; 12: 505-12.
25. Roten LT, Johnson M, Forsmo S et al. Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur JHum Genet 2009; 17(2): 250-7.
26. Oudejans CB, Mulders J, Lachmeijer AM et al. The parent-of-origin effect of 10q22 in pre-eclamptic females coincides with two regions clustered for genes with down-regulated expression in androgenetic placentas. Mol Hum Reprod 2004; 10: 589-98.
27. Graves J A M. Genomic imprinting, development and disease - is pre-eclampsia caused by a maternally imprinted gene? Reprod Fert Develop 1998; 10: 23-9.
28. van Dijk M, Mulders J, Poutsma A et al. Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 2005; 37: 514-9.
29. Iglesias-Platas I, Monk D, Jebbink J et al. STOX1 is not imprinted and is not likely to be involved in pre-eclampsia. Nat Genet 2007; 39: 279-80.
30. The Wellcome Trust Case Control Consortium. Genome-wide association study of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-78.
31. Zeggini E, Weedon M N, Lindgren CM et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-41.
32. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-7. http://www.ncbi.nlm.nih.gov/projects/SNP
33. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-319.
34. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851-62. http://www.hapmap.org
35. Zeggini E, Scott L J, Saxena R, Voight B F. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40: 638-45.
36. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
37. The GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005; 77: 127-31.
38. Magnus P, Irgens L, Haug K et al. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 2006; 35: 1146-50.
39. Hiby S, Walker J, O’shaughnessy K et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200: 957-65.
40. Maynard S E, Min J Y, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-58.
41. Boyd P A, Lindenbaum R H, Redman C. Pre-eclampsia and trisomy 13: a possible association. Lancet 1987; 2 (8556): 425-7.
42. Bdolah Y, Palomaki G E, Yaron Y et al. Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol 2006; 194: 239-45.
43. Lyssenko V, Jonsson A, Almgren P et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008; 359: 2220-32.